My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 139

    1.

    DURAbility of basal versus lispro mix 75/25 insulin efficacy (DURABLE) trial 24-week results: safety and efficacy of insulin lispro mix 75/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes.

    Buse JB, Wolffenbuttel BH, Herman WH, Shemonsky NK, Jiang HH, Fahrbach JL, Scism-Bacon JL, Martin SA.

    Diabetes Care. 2009 Jun;32(6):1007-13. Epub 2009 Mar 31.PMID: 19336625 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

    Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.

    Clin Ther. 2007 Nov;29(11):2349-64.PMID: 18158076 [PubMed - indexed for MEDLINE]Related articles

    3.

    Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy.

    Malone JK, Kerr LF, Campaigne BN, Sachson RA, Holcombe JH; Lispro Mixture-Glargine Study Group.

    Clin Ther. 2004 Dec;26(12):2034-44. Erratum in: Clin Ther. 2005 Jul;27(7):1112. PMID: 15823767 [PubMed - indexed for MEDLINE]Related articles

    4.

    Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.

    Tîrgovişte CI, Străchinariu R, Farcaşiu E, Milicevic Z, Teodorescu G.

    Rom J Intern Med. 2003;41(2):153-62.PMID: 15526500 [PubMed - indexed for MEDLINE]Related articles

    5.

    Twice-daily pre-mixed insulin rather than basal insulin therapy alone results in better overall glycaemic control in patients with Type 2 diabetes.

    Malone JK, Bai S, Campaigne BN, Reviriego J, Augendre-Ferrante B.

    Diabet Med. 2005 Apr;22(4):374-81.PMID: 15787659 [PubMed - indexed for MEDLINE]Related articles

    6.

    A comparison of intensive mixture therapy with basal insulin therapy in insulin-naïve patients with type 2 diabetes receiving oral antidiabetes agents.

    Jacober SJ, Scism-Bacon JL, Zagar AJ.

    Diabetes Obes Metab. 2006 Jul;8(4):448-55.PMID: 16776752 [PubMed - indexed for MEDLINE]Related articles

    7.

    Advancing insulin therapy in type 2 diabetes previously treated with glargine plus oral agents: prandial premixed (insulin lispro protamine suspension/lispro) versus basal/bolus (glargine/lispro) therapy.

    Rosenstock J, Ahmann AJ, Colon G, Scism-Bacon J, Jiang H, Martin S.

    Diabetes Care. 2008 Jan;31(1):20-5. Epub 2007 Oct 12.PMID: 17934150 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients.

    Rosenstock J, Sugimoto D, Strange P, Stewart JA, Soltes-Rak E, Dailey G.

    Diabetes Care. 2006 Mar;29(3):554-9.PMID: 16505505 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.

    Heine RJ, Van Gaal LF, Johns D, Mihm MJ, Widel MH, Brodows RG; GWAA Study Group.

    Ann Intern Med. 2005 Oct 18;143(8):559-69.PMID: 16230722 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

    Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

    Ann Intern Med. 2008 Oct 21;149(8):531-9.PMID: 18936501 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Comparison of insulin lispro mixture 25/75 with insulin glargine during a 24-h standardized test-meal period in patients with Type 2 diabetes.

    Roach P, Malone JK.

    Diabet Med. 2006 Jul;23(7):743-9.PMID: 16842478 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effect of two starting insulin regimens in patients with type II diabetes not controlled on a combination of oral antihyperglycemic medications.

    Milicevic Z, Hancu N, Car N, Ivanyi T, Schwarzenhofer M, Jermendy G.

    Exp Clin Endocrinol Diabetes. 2009 May;117(5):223-9. Epub 2009 Mar 19.PMID: 19301232 [PubMed - indexed for MEDLINE]Related articles

    13.

    Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.

    Yki-Järvinen H, Dressler A, Ziemen M; HOE 901/300s Study Group.

    Diabetes Care. 2000 Aug;23(8):1130-6.PMID: 10937510 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes.

    Hollander P, Cooper J, Bregnhøj J, Pedersen CB.

    Clin Ther. 2008 Nov;30(11):1976-87.PMID: 19108786 [PubMed - indexed for MEDLINE]Related articles

    15.

    Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial.

    Bretzel RG, Nuber U, Landgraf W, Owens DR, Bradley C, Linn T.

    Lancet. 2008 Mar 29;371(9618):1073-84. Erratum in: Lancet. 2008 Aug 30;372(9640):718. PMID: 18374840 [PubMed - indexed for MEDLINE]Related articles

    16.

    Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial.

    Kennedy L, Herman WH, Strange P, Harris A; GOAL AIC Team.

    Diabetes Care. 2006 Jan;29(1):1-8.PMID: 16373887 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.

    Ilag LL, Kerr L, Malone JK, Tan MH.

    Clin Ther. 2007 Jun;29(6 Pt 1):1254-70. Review.PMID: 18036388 [PubMed - indexed for MEDLINE]Related articles

    18.

    Prandial insulin substitution with insulin lispro or insulin lispro mid mixture vs. basal therapy with insulin glargine: a randomized controlled trial in patients with type 2 diabetes beginning insulin therapy.

    Kazda C, Hülstrunk H, Helsberg K, Langer F, Forst T, Hanefeld M.

    J Diabetes Complications. 2006 May-Jun;20(3):145-52.PMID: 16632233 [PubMed - indexed for MEDLINE]Related articles

    19.

    Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin.

    Rosenstock J, Schwartz SL, Clark CM Jr, Park GD, Donley DW, Edwards MB.

    Diabetes Care. 2001 Apr;24(4):631-6.PMID: 11315821 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Biphasic insulin aspart 30 three times daily is more effective than a twice-daily regimen, without increasing hypoglycemia, in Chinese subjects with type 2 diabetes inadequately controlled on oral antidiabetes drugs.

    Yang W, Ji Q, Zhu D, Yang J, Chen L, Liu Z, Yu D, Yan L.

    Diabetes Care. 2008 May;31(5):852-6. Epub 2008 Feb 11.PMID: 18268073 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity